Allena Pharmaceuticals Inc. (ALNA) Could Be Sitting On A Goldmine – Stocks Register
Home  »  Business   »  Allena Pharmaceuticals Inc. (ALNA) Could Be Sittin...

Allena Pharmaceuticals Inc. (ALNA) Could Be Sitting On A Goldmine

Allena Pharmaceuticals Inc. (NASDAQ:ALNA) concluded the trading at $0.47 on Thursday, January 13 with a fall of -2.92% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $0.48 and 5Y monthly beta was reading 2.08 with its price kept floating in the range of $0.4641 and $0.485 on the day. Considering stock’s 52-week price range provides that ALNA hit a high price of $2.78 and saw its price falling to a low level of $0.46 during that period. Over a period of past 1-month, stock came subtracting -23.97% in its value.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


With its current market valuation of $35.90 million, Allena Pharmaceuticals Inc. is set to declare its quarterly results on Mar 07, 2022 – Mar 11, 2022. Analysts are in estimates of -$0.16 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$0.76 for 2021 with estimates of that growing to -$0.68 in next year. These estimates are suggesting current year growth of 24.80% for EPS and 10.50% growth next year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review ALNA stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.

Digging deeper we become aware of the PEG ratio of the ALNA stock which is currently positioned at 0. It further provides that stock’s current price level is -23.47% away from its 20-day simple moving average and is -33.68% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 31.40 while volatility remained at 6.20% over the past week which changes to 9.45% when measuring it over the past month. Beta is valued at 2.06, while measure of average true range or ATR is currently at 0.05.

In comparing Allena Pharmaceuticals Inc. (ALNA)’s stock with other industry players reveals that stock’s current price change of -2.92% and that of -70.00% over the past 12 months. Industry’s another major player Omeros Corporation (OMER) has fall -5.07% down in previous session, but over the past year has faced a fall of -67.76% over the same period. Allena Pharmaceuticals Inc. has a P/E ratio of 0. On the other hand, the S&P 500 Index was down -1.42% in the last trading session while the Dow Jones Industrial closed the session lower at -0.49%.

Having a second look at Allena Pharmaceuticals Inc. (NASDAQ:ALNA) provides that stock’s average daily trading volume for 3 months was 3.97 million. Number of outstanding shares of the stock stood at 85.37 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

The percentage of outstanding shares held by the insiders is 0.40% while it is 23.70% for the institutional holders. Subtraction of -21.52% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.

Leave a Comment

Your email address will not be published. Required fields are marked *

Related Videos

Related Posts



Download Free eBook For


100% free. stop anytime no spam